Jung Cheol Park

Prof. Dr. Jung Cheol Park

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Stroke
Verified
Journal Article
Closed access
PDF file
MKMoinay Kim
Moinay Kim
JBJoonho Byun
Joonho Byun
YCYeongu Chung
Yeongu Chung
SLSi Un Lee
Si Un Lee
JPJi Eun Park
Ji Eun Park
SLSeungjoo Lee
Seungjoo Lee
Background and Purpose: Patients with intracerebral hemorrhage (ICH) have oxidative stress. Oxidative stress contributes to the development and progression of perihematomal edema (PHE) in brain hemorrhage patients. We hypothesized that reactive oxygen species (ROS) scavengers might have a neuroprotective role in the acute period of patients with ICH. Methods: This prospective, multicenter, single-blind, randomized study was conducted between June 2017 and October 2019. Intracranial bleeding, including spontaneous ICH, secondary ICH due to vascular anomalies, venous thrombosis, neoplasms, or hemorrhagic infarction, were included in our study. These ROS scavengers were given for 14 days with a dose of N-acetylcysteine 2000 mg/d and selenium 1600 µg/d intravenously. Other patients received a placebo. The primary outcome was hemorrhage and PHE volume changes in 2-week follow-up computed tomography between ROS scavenger versus placebo groups. Results: In total, 448 patients were enrolled with 123 patients remaining after applying the inclusion and exclusion criteria. There were no significant differences in baseline characteristics between the ROS scavenger (n=57) and placebo (n=66) groups. No significant differences in baseline hematoma and PHE volumes were observed but 2 weeks follow-up computed tomography showed significant differences in PHE volume (21.90±17.63 versus 30.66±32.35, P <0.01) and PHE ratio (1.19±0.73 versus 2.05±1.27, P <0.01). Among clinical factors, time to reach target Richmond Agitation Sedation Scale (5.98 hours [95% CI, 4.82–7.241 versus 8.42 hours], [95% CI, 6.57–10.77], P <0.01) and the length of intensive care unit stays (6.46 days [95% CI, 2.38–10.55 versus 12.66 days], [95% CI, 8.47–16.85], P <0.01) were significantly shortened among patients who received ROS scavengers than among patients who did not receive ROS scavenger. Conclusions: ROS scavenger showed a significantly reduced PHE volume, time to reach target Richmond Agitation Sedation Scale, and shortened length of intensive care unit stay in patients with acute ICH. Early and high doses of ROS scavengers in a combination regimen may have played a key role in obtaining a favorable outcome in our study. Registration: URL: https://cris.nih.go.kr/cris/en ; Unique identifier: KCT0004628.

1 January 2020 in World Neurosurgery
Verified
Journal Article
Closed access
MKMoinay Kim
Moinay Kim
SLSeungjoo Lee
Seungjoo Lee
JPJung Cheol Park
Jung Cheol Park
DJDong-Min Jang
Dong-Min Jang
SHSeung Il Ha
Seung Il Ha
WPWonhyoung Park
Wonhyoung Park

1 July 2020 in Journal of Korean Neurosurgical Society
Verified
Journal Article
Open access
PDF file
JBJoonho Byun
Joonho Byun
DKDo Hoon Kwon
Do Hoon Kwon
DLDo Heui Lee
Do Heui Lee
WPWonhyoung Park
Wonhyoung Park
JPJung Cheol Park
Jung Cheol Park
JAJae Sung Ahn
Jae Sung Ahn
Arteriovenous malformations (AVMs) are congenital anomalies of the cerebrovascular system. AVM harbors 2.2% annual hemorrhage risk in unruptured cases and 4.5% annual hemorrhage risk of previously ruptured cases. Stereotactic radiosurgery (SRS) have been shown excellent treatment outcomes for patients with small- to moderated sized AVM which can be achieved in 80-90% complete obliteration rate with a 2-3 years latency period. The most important factors are associated with obliteration after SRS is the radiation dose to the AVM. In our institutional clinical practice, now 22 Gy (50% isodose line) dose of radiation has been used for treatment of cerebral AVM in single-session radiosurgery. However, dose-volume relationship can be unfavorable for large AVMs when treated in a single-session radiosurgery, resulting high complication rates for effective dose. Thus, various strategies should be considered to treat large AVM. The role of pre-SRS embolization is permanent volume reduction of the nidus and treat high-risk lesion such as AVM-related aneurysm and high-flow arteriovenous shunt. Various staging technique of radiosurgery including volume-staged radiosurgery, hypofractionated radiotherapy and dose-staged radiosurgery are possible option for large AVM. The incidence of post-radiosurgery complication is varied, the incidence rate of radiological post-radiosurgical complication has been reported 30-40% and symptomatic complication rate was reported from 8.1% to 11.8%. In the future, novel therapy which incorporate endovascular treatment using liquid embolic material and new radiosurgical technique such as gene or cytokine-targeted radio-sensitization should be needed.


1 May 2019 in World Neurosurgery
Verified
Journal Article
Closed access
MKMoinay Kim
Moinay Kim
HLHeui Seung Lee
Heui Seung Lee
SLSeungjoo Lee
Seungjoo Lee
JPJung Cheol Park
Jung Cheol Park
JAJae Sung Ahn
Jae Sung Ahn
WPWonhyoung Park
Wonhyoung Park

19 June 2014 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
KYKuhyun Yang
Kuhyun Yang
JPJung Cheol Park
Jung Cheol Park
JAJae Sung Ahn
Jae Sung Ahn
DKDo Hoon Kwon
Do Hoon Kwon
BKByung Duk Kwun
Byung Duk Kwun
CKChang Jin Kim
Chang Jin Kim